BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15345765)

  • 1. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
    dosReis S; Owens PL; Puccia KB; Leaf PJ
    Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental health services for youths in foster care and disabled youths.
    dosReis S; Zito JM; Safer DJ; Soeken KL
    Am J Public Health; 2001 Jul; 91(7):1094-9. PubMed ID: 11441737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
    Chen CY; Gerhard T; Winterstein AG
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant treatment for psychiatric and seizure indications among youths.
    Zito JM; Safer DJ; Gardner JF; Soeken K; Ryu J
    Psychiatr Serv; 2006 May; 57(5):681-5. PubMed ID: 16675763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
    Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
    Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.
    Burcu M; Zito JM; Ibe A; Safer DJ
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
    Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
    Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental Health Service Use by Medicaid-Enrolled Children and Adolescents in Primary Care Safety-Net Clinics.
    Cummings JR; Ji X; Druss BG
    Psychiatr Serv; 2020 Apr; 71(4):328-336. PubMed ID: 31960778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
    Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
    Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mental health services among older youths in foster care.
    McMillen JC; Scott LD; Zima BT; Ollie MT; Munson MR; Spitznagel E
    Psychiatr Serv; 2004 Jul; 55(7):811-7. PubMed ID: 15232022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental health care utilization and expenditures by children in foster care.
    Harman JS; Childs GE; Kelleher KJ
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1114-7. PubMed ID: 11074852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes.
    Enns JE; Randall JR; Smith M; Chateau D; Taylor C; Brownell M; Bolton JM; Burland E; Katz A; Katz LY; Nickel NC
    Can J Psychiatry; 2017 Jun; 62(6):403-412. PubMed ID: 28146649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A profile of children with disabilities receiving SSI: highlights from the National Survey of SSI Children and Families.
    Rupp K; Davies PS; Newcomb C; Iams H; Becker C; Mulpuru S; Ressler S; Romig K; Miller B
    Soc Secur Bull; 2005-2006; 66(2):21-48. PubMed ID: 16878426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic medication use among Kansas Medicaid youths with disabilities.
    Shireman TI; Reichard A; Rigler SK
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):107-15. PubMed ID: 15741792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of psychiatric disorders in youths across five sectors of care.
    Garland AF; Hough RL; McCabe KM; Yeh M; Wood PA; Aarons GA
    J Am Acad Child Adolesc Psychiatry; 2001 Apr; 40(4):409-18. PubMed ID: 11314566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Partnership Access Line: evaluating a child psychiatry consult program in Washington State.
    Hilt RJ; Romaire MA; McDonell MG; Sears JM; Krupski A; Thompson JN; Myers J; Trupin EW
    JAMA Pediatr; 2013 Feb; 167(2):162-8. PubMed ID: 23247331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple psychotropic medication use for youths: a two-state comparison.
    dosReis S; Zito JM; Safer DJ; Gardner JF; Puccia KB; Owens PL
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):68-77. PubMed ID: 15741788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.